Debt Burden Makes Horizon Pharma An Attractive Short – Seekingalpha.com

Horizon Pharma (HZNP) is on investors’ radars, as the company launched DUEXIS in January 2012 and has an upcoming PDUFA date of July 26 for its second product, RAYOS, a modified-release low dose prednisone. The stock has enjoyed a ~100% run-up in its share …